Testosterone
"Testosterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
Descriptor ID |
D013739
|
MeSH Number(s) |
D04.210.500.054.079.429.824 D06.472.334.851.968.984
|
Concept/Terms |
Testosterone- Testosterone
- 17-beta-Hydroxy-4-Androsten-3-one
- 17 beta Hydroxy 4 Androsten 3 one
8-Isotestosterone- 8-Isotestosterone
- 8 Isotestosterone
- 17-beta-Hydroxy-8 alpha-4-Androsten-3-one
- 17 beta Hydroxy 8 alpha 4 Androsten 3 one
|
Below are MeSH descriptors whose meaning is more general than "Testosterone".
Below are MeSH descriptors whose meaning is more specific than "Testosterone".
This graph shows the total number of publications written about "Testosterone" by people in this website by year, and whether "Testosterone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 | 1996 | 0 | 1 | 1 | 1997 | 1 | 0 | 1 | 1998 | 0 | 1 | 1 | 1999 | 0 | 2 | 2 | 2000 | 0 | 1 | 1 | 2001 | 3 | 1 | 4 | 2002 | 1 | 0 | 1 | 2003 | 2 | 3 | 5 | 2004 | 0 | 1 | 1 | 2005 | 2 | 6 | 8 | 2006 | 2 | 2 | 4 | 2007 | 3 | 6 | 9 | 2008 | 5 | 8 | 13 | 2009 | 4 | 3 | 7 | 2010 | 9 | 4 | 13 | 2011 | 2 | 3 | 5 | 2012 | 6 | 3 | 9 | 2013 | 9 | 5 | 14 | 2014 | 15 | 2 | 17 | 2015 | 8 | 4 | 12 | 2016 | 5 | 5 | 10 | 2017 | 8 | 4 | 12 | 2018 | 6 | 9 | 15 | 2019 | 7 | 5 | 12 | 2020 | 9 | 1 | 10 | 2021 | 5 | 3 | 8 | 2022 | 4 | 6 | 10 | 2023 | 2 | 7 | 9 | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Testosterone" by people in Profiles.
-
Nokoff NJ, Nemkov T, Bothwell S, Cree MG, Fuller KNZ, Keller AC, Kelsey MM, Nadeau KJ, Moreau KL. Differences in cardiorespiratory fitness by gonadotropin-releasing hormone agonist treatment before and after testosterone in transgender adolescents. J Appl Physiol (1985). 2024 Nov 01; 137(5):1470-1483.
-
Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
-
Fox MM, Hahn-Holbrook J, Sandman CA, Marino JA, Glynn LM, Davis EP. Mothers' prenatal distress accelerates adrenal pubertal development in daughters. Psychoneuroendocrinology. 2024 Feb; 160:106671.
-
Newfield RS, Sarafoglou K, Fechner PY, Nokoff NJ, Auchus RJ, Vogiatzi MG, Jeha GS, Giri N, Roberts E, Sturgeon J, Chan JL, Farber RH. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2023 10 18; 108(11):2871-2878.
-
Hudson J, Cruickshank M, Quinton R, Aucott L, Wu F, Grossmann M, Bhasin S, Snyder PJ, Ellenberg SS, Travison TG, Brock GB, Gianatti EJ, van der Schouw YT, Emmelot-Vonk MH, Giltay EJ, Hackett G, Ramachandran S, Svartberg J, Hildreth KL, Antonic KG, Tenover JL, Tan HM, Ho Chee Kong C, Tan WS, Marks LS, Ross RJ, Schwartz RS, Manson P, Roberts SA, Skovsager Andersen M, Velling Magnussen L, Aceves-Martins M, Gillies K, Hern?ndez R, Oliver N, Dhillo WS, Bhattacharya S, Brazzelli M, Jayasena CN. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. Lancet Healthy Longev. 2023 10; 4(10):e561-e572.
-
van Eeghen SA, Wiepjes CM, T'Sjoen G, Nokoff NJ, den Heijer M, Bjornstad P, van Raalte DH. Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1545-1554.
-
Roy MK, Wilkerson RB, Alexander K, Nokoff NJ, Cree-Green M, D'Alessandro A. Longitudinal metabolic study of red blood cells from patients undergoing gender-affirming testosterone therapy. Blood Adv. 2023 08 22; 7(16):4269-4277.
-
Tahmasbi Sohi M, Cali M, Forster JE, Kiseljak-Vassiliades K, Wierman ME. Short term effects of intraarticular triamcinolone acetonide injection on serum testosterone, luteinizing hormone, and follicle stimulating hormone levels in male veterans: A prospective pilot study. PM R. 2024 Jan; 16(1):6-13.
-
Knight EL, Graham-Engeland JE, Sliwinski MJ, Engeland CG. Greater Ecologically Assessed Positive Experiences Predict Heightened Sex Hormone Concentrations Across Two Weeks in Older Adults. J Gerontol B Psychol Sci Soc Sci. 2023 05 26; 78(6):1007-1017.
-
Nokoff NJ, Senefeld J, Krausz C, Hunter S, Joyner M. Sex Differences in Athletic Performance: Perspectives on Transgender Athletes. Exerc Sport Sci Rev. 2023 07 01; 51(3):85-95.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|